Raising regulatory approvals, increasing biologics pipelines, and escalating financial commitment in next-era peptide modalities carry on to make 2025 a pivotal growth yr for the marketplace.CordenPharma is an additional key CDMO with substantial US functions, particularly in Colorado. They focus on having peptide initiatives from early-phase progr